NAEJA PHARMACEUTICAL INC has a total of 34 patent applications. Its first patent ever was published in 1991. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NEUROCRINE BIOSCIENCES INC, HEPAGENE THERAPEUTICS INC and EVOTEC INT GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | Australia | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | United States | 4 | |
#6 | China | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Singh Rajeshwar | 23 |
#2 | Micetich Ronald G | 18 |
#3 | Kaleta Jadwiga | 13 |
#4 | Thomas George | 11 |
#5 | Micetich Ronald George | 10 |
#6 | Maiti Samarendra N | 9 |
#7 | Whittaker Mark | 8 |
#8 | Reddy Andhe V Narender | 8 |
#9 | Reddy Andhe V N | 8 |
#10 | Ding Qizhu | 8 |
Publication | Filing date | Title |
---|---|---|
WO2014141132A1 | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS | |
US2013225554A1 | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors | |
AU5057001A | Dihydropyrimidine derivatives as cysteine protease inhibitors | |
AU5528299A | Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s) | |
US6232305B1 | Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |